ASPAC III Acquisition (ASPC) risk factors
Item 1A of every ASPAC III Acquisition Corp. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors78 risks21 new9 dropped35 reworded
The company entered into a $217,860,000 merger agreement with Bioserica, backed by a voting agreement from a supporting shareholder. Cash on hand dropped to $871,350 while working capital stands at $419,761 as of December 31, 2025. Shareholders approved extending the business combination deadline up to November 12, 2026.
Filed Mar 04, 2026 - FY2024 10-K risk factors66 risks
The company relies heavily on completing an initial business combination by November 12, 2025 to survive. Management faces significant conflicts of interest due to multiple business affiliations. Working capital relies entirely on loans from the sponsor or affiliates.
Filed Mar 05, 2025